1. Home
  2. PODD vs CRBG Comparison

PODD vs CRBG Comparison

Compare PODD & CRBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • CRBG
  • Stock Information
  • Founded
  • PODD 2000
  • CRBG 1957
  • Country
  • PODD United States
  • CRBG United States
  • Employees
  • PODD N/A
  • CRBG N/A
  • Industry
  • PODD Medical/Dental Instruments
  • CRBG Life Insurance
  • Sector
  • PODD Health Care
  • CRBG Finance
  • Exchange
  • PODD Nasdaq
  • CRBG Nasdaq
  • Market Cap
  • PODD 16.5B
  • CRBG 17.1B
  • IPO Year
  • PODD 2007
  • CRBG 2022
  • Fundamental
  • Price
  • PODD $260.12
  • CRBG $30.46
  • Analyst Decision
  • PODD Buy
  • CRBG Buy
  • Analyst Count
  • PODD 15
  • CRBG 12
  • Target Price
  • PODD $251.53
  • CRBG $35.17
  • AVG Volume (30 Days)
  • PODD 609.1K
  • CRBG 4.3M
  • Earning Date
  • PODD 11-07-2024
  • CRBG 11-04-2024
  • Dividend Yield
  • PODD N/A
  • CRBG 3.02%
  • EPS Growth
  • PODD 235.68
  • CRBG N/A
  • EPS
  • PODD 5.74
  • CRBG N/A
  • Revenue
  • PODD $1,983,900,000.00
  • CRBG $15,976,000,000.00
  • Revenue This Year
  • PODD $22.33
  • CRBG N/A
  • Revenue Next Year
  • PODD $18.50
  • CRBG $7.92
  • P/E Ratio
  • PODD $45.35
  • CRBG N/A
  • Revenue Growth
  • PODD 27.42
  • CRBG N/A
  • 52 Week Low
  • PODD $160.19
  • CRBG $19.26
  • 52 Week High
  • PODD $279.40
  • CRBG $34.66
  • Technical
  • Relative Strength Index (RSI)
  • PODD 63.27
  • CRBG 47.03
  • Support Level
  • PODD $233.48
  • CRBG $30.49
  • Resistance Level
  • PODD $276.57
  • CRBG $31.27
  • Average True Range (ATR)
  • PODD 8.53
  • CRBG 0.88
  • MACD
  • PODD 2.16
  • CRBG -0.25
  • Stochastic Oscillator
  • PODD 63.19
  • CRBG 16.00

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About CRBG Corebridge Financial Inc.

Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments namely Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.

Share on Social Networks: